Two-dimensional radiotherapy and docetaxel in treatment of stage III non-small cell lung carcinoma: No good survival due to radiation pneumonitis

Lung Cancer

Volumn 43, Issue 2, 2004, Pages 241-242

  Dinçbas, Fazilet Oner ^a   Atalar, Banu ^a   Koca, Sedat ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL;

CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; DRUG RESPONSE; DYSPNEA; ESOPHAGITIS; HUMAN; HYPERSENSITIVITY; INFECTION; IRRADIATION; LETTER; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PNEUMONIA; RESPIRATORY TRACT DISEASE;

EID: 1642534411     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2003.08.022     Document Type: Editorial

References (10)

1. Onishi H., Kuriyama K., Yamaguchi M., Komiyama T., Tanaka S., Araki T.et al. Concurrent two-dimensional radiotherapy and weekly docetaxel in the treatment of stage III non-small cell lung cancer: a good local response but no good survival due to radiation pneumonitis. Lung Cancer. 40:2003;79-84.
2. Schweitzer V.G., Juilard G.J.F., Bajada C.L., Parker R.G. Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel. Cancer. 76:1995;1069-1072.
3. Khan A., McNally D., Tutschka P.J., Bilgrami S. Paclitaxel-induced acute bilateral pneumonitis. Ann Pharmacother. 31:1997;1471-1474.
4. Choy H., Rodriguez F., Wilcox B.et al. Radiation sensitizing effects of Taxotere. Proc. Am. Assoc. Cancer Res. 33:1992;500.
5. Koukourakis M.I., Kourousis C., Kamilaki M., Koukouraki S., Giatromanolaki A., Kakolyris S., Kotsakis A.et al. Weekly docetaxel and concomitant boost radiotherapy for non-small-cell lung cancer. A phase I/II dose escalation trial. Eur. J. Cancer. 34:1998;838-844.
6. Koukourakis M.I., Giatromanolaki A., Schiza S., Kakolyris S., Georgoulias V. Concurrent twice-a-week docetaxel and radiotherapy: a dose escalation trial with immunological toxicity evaluation. Int. J. Radiat Oncol. Biol. Phys. 43:1999;107-114.
7. Koukourakis MI, Bahlitzanakis N, Froudarakis M, Giatromanolaki A, Georgoulias V, Koumiotaki S, Christodoulou M, et al. Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma. Br J Cancer 1999;80(11):1792-6.
8. Wu H., Bang Y., Choi E.K., Ahn Y.C., Kim Y.W., Lim T.H.et al. Phase I study of weekly docetaxel and cisplatin concurrent with thoracic radiotherapy in stage III non-small-cell lung cancer. Int. J. Radiat Oncol. Biol. Phys. 52:2002;75-80.
9. Choy H, DeVore RF, Hande KR, Porter LL, Rosenblatt PA, Slovis B, Laporte K, Shyr, Johnson DH. Phase I trial of outpatient weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for stage III unresectable non-small-cell lung cancer: a Vanderbilt cancer center affiliate network (VCCAN) trial. Lung Cancer 2001;34:441-9.
10. Mauer A.M., Masters G.A., Haraf D.J., Hoffman P.C., Watson S.M., Golomb H.M.et al. Phase I study of docetaxel with concomitant thoracic radiation therapy. J. Clin. Oncol. 16:1998;159-164.